Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

about

Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.

P2860

Q40634245-7E2E8475-3B6F-4F4B-92F2-793C437281A4

P2860

Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

Item

http://www.wikidata.org/entity/Q42095619

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@en

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@nl

type

Item

label

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@en

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@nl

prefLabel

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@en

Optimizing an 18F-NaF and 18F- ...... ion-resistant prostate cancer.

@nl

P1476

Optimizing an 18F-NaF and 18F- ...... tion-resistant prostate cancer

@en

P2093

Glenn Liu

http://www.w3.org/2001/XMLSchema#string

Robert Jeraj

http://www.w3.org/2001/XMLSchema#string

Scott Perlman

http://www.w3.org/2001/XMLSchema#string

P2860

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer

F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CT.

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.

Cumulative input function method for linear compartmental models and spectral analysis in PET

Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT

Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.

P304

1174-1180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MNM.0000000000000383

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Urban Simoncic

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26378490

http://www.w3.org/2001/XMLSchema#string

P932

4626289

http://www.w3.org/2001/XMLSchema#string

Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

about

P2860

P2860

Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932